IL216649A0 - Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide - Google Patents
Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamideInfo
- Publication number
- IL216649A0 IL216649A0 IL216649A IL21664911A IL216649A0 IL 216649 A0 IL216649 A0 IL 216649A0 IL 216649 A IL216649 A IL 216649A IL 21664911 A IL21664911 A IL 21664911A IL 216649 A0 IL216649 A0 IL 216649A0
- Authority
- IL
- Israel
- Prior art keywords
- carbamoylamino
- polymorphs
- carboxamide
- phenoxy
- trifluoromethyl
- Prior art date
Links
- MLDQJTXFUGDVEO-UHFFFAOYSA-N BAY-43-9006 Chemical compound C1=NC(C(=O)NC)=CC(OC=2C=CC(NC(=O)NC=3C=C(C(Cl)=CC=3)C(F)(F)F)=CC=2)=C1 MLDQJTXFUGDVEO-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1395CH2009 | 2009-06-12 | ||
| PCT/EP2010/058006 WO2010142678A2 (fr) | 2009-06-12 | 2010-06-08 | Polymorphes de 4-[4-[[4-chloro-3-(trifluorométhyl)phényl]carbamoylamino]phénoxy]-n-méthyl-pyridine-2-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL216649A0 true IL216649A0 (en) | 2012-02-29 |
Family
ID=42931997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL216649A IL216649A0 (en) | 2009-06-12 | 2011-11-28 | Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2440531A2 (fr) |
| IL (1) | IL216649A0 (fr) |
| WO (1) | WO2010142678A2 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2775296A1 (fr) | 2009-09-24 | 2011-03-31 | Ranbaxy Laboratories Limited | Polymorphes de sels d'addition acide de sorafenib |
| WO2012071425A1 (fr) | 2010-11-22 | 2012-05-31 | Teva Pharmaceutical Industries Ltd. | Formes à l'état solide de bésylate de sorafénib et procédés de préparation |
| EP2852574B1 (fr) * | 2012-05-21 | 2020-02-05 | Hetero Research Foundation | Procédé de préparation du polymorphe iii de tosylate de sorafénib |
| WO2013175483A1 (fr) * | 2012-05-23 | 2013-11-28 | Shilpa Medicare Limited | Procédé pour la préparation de tosylate de sorafénib cristallin |
| CN103570613B (zh) * | 2012-07-18 | 2016-06-15 | 苏州泽璟生物制药有限公司 | 氘代ω-二苯基脲或其盐的多晶型物 |
| CN106336377A (zh) * | 2015-07-17 | 2017-01-18 | 苏州亚宝药物研发有限公司 | 一种甲苯磺酸索拉非尼晶型ⅱ的制备方法 |
| WO2017101548A1 (fr) * | 2015-12-14 | 2017-06-22 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Cristal d'hémi-p-tosylate monohydrate de sorafénib et son procédé de préparation |
| CN107759517A (zh) * | 2016-08-23 | 2018-03-06 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种甲苯磺酸索拉非尼晶型ⅰ的制备方法 |
| RU2766288C2 (ru) * | 2020-03-30 | 2022-03-11 | Общество с ограниченной ответственностью "АКСЕЛЬФАРМ" | Аморфная форма 4-{ 4-[({ [4-хлор-3-(трифторметил)фенил]амино} карбонил)-амино]фенокси} -n-метилпиридин-2-карбоксамида тозилата (варианты), способ её получения и применение для лечения онкологических заболеваний |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE395905T1 (de) * | 2004-08-27 | 2008-06-15 | Bayer Pharmaceuticals Corp | Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs |
| DK1797038T3 (da) * | 2004-09-29 | 2012-09-03 | Bayer Pharma AG | Termodynamisk stabil form af bay 43-9006-tosylat |
| ATE482693T1 (de) * | 2005-03-07 | 2010-10-15 | Bayer Schering Pharma Ag | Pharmazeutische zusammensetzung mit einem omega- carboxyaryl-substituierten diphenylharnstoff zur behandlung von krebs |
| WO2007038524A2 (fr) * | 2005-09-28 | 2007-04-05 | Ssci, Inc. | Methodes de co-cristallisation |
| JP2009543797A (ja) * | 2006-07-10 | 2009-12-10 | エラン ファーマ インターナショナル，リミティド | ナノ粒子ソラフェニブ製剤 |
| WO2009106825A1 (fr) * | 2008-02-27 | 2009-09-03 | Cipla Limited | Polymorphes de sorafénib et leurs sels |
| CN101584661B (zh) * | 2009-06-10 | 2011-06-08 | 北京大学 | 一种供口服或静脉注射用索拉非尼自微乳化给药系统及其制备方法 |
-
2010
- 2010-06-08 EP EP10722711.8A patent/EP2440531A2/fr not_active Withdrawn
- 2010-06-08 WO PCT/EP2010/058006 patent/WO2010142678A2/fr not_active Ceased
-
2011
- 2011-11-28 IL IL216649A patent/IL216649A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010142678A3 (fr) | 2011-03-24 |
| WO2010142678A2 (fr) | 2010-12-16 |
| EP2440531A2 (fr) | 2012-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL216649A0 (en) | Polymorphs of 4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-n-methyl-pyridine-2-carboxamide | |
| AP3074A (en) | Haloalkyl heteroaryl benzamide compounds | |
| SI2623497T1 (sl) | Megluminska sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida | |
| ZA201209477B (en) | A personal care composition comprising a near-terminal branched compound | |
| PL2789617T3 (pl) | Sposób wytwarzania enancjomerów związków spiro-oksyndolowych | |
| EP2379494A4 (fr) | Oxydation de composés alkylaromatiques | |
| ZA201102892B (en) | Pyrazolylaminopyridines as inhibitors of fak | |
| ZA201400281B (en) | Salts and polymorphs of a tetracycline compound | |
| ZA201108648B (en) | A novel formulation of naproxen | |
| AP3659A (en) | A novel formulation of meloxicam | |
| EP2249650A4 (fr) | Anilinopyridines utilisées comme inhibiteurs de fak | |
| ZA201108644B (en) | A novel formulation of metaxalone | |
| IL197956A0 (en) | Polymorphs of nicotinic intermediates | |
| EP2195309A4 (fr) | Polymorphes de sels de l'ésoméprazole | |
| EP2638013A4 (fr) | Nouveaux polymorphes de pivastatine calcique | |
| IL248077B (en) | Formulations, salts and polymers of transnorsertraline and their uses | |
| EP2537832A4 (fr) | Méthode de préparation de 2-[2-(6-chloropyrimidin-4-yloxy)phényl]-3-méthoxyacrylate de (e)-méthyle | |
| DK2271865T3 (da) | Fordeler med en drejelig U-formet forbindelseskanal | |
| ZA201202859B (en) | Polymorphs of sorafeinib acid addition salts | |
| EP2393786A4 (fr) | Nouveaux polymorphes du lopinavir | |
| WO2011076711A3 (fr) | Polymorphes de 4-[4-[[4-chloro-3-(trifluorométhyl)phényl]carbamoylamino]phénoxy]-n-méthylpyridine-2-carboxamide | |
| EP2376452A4 (fr) | Nouveau polymorphe de sulfate d'atazanavir | |
| IL209326A0 (en) | Solid state forms of aliskiren compounds | |
| IL257014A (en) | A novel formulation of meloxicam | |
| UA13878S (uk) | Головка сиру |